Saltar al contenido
Merck

Effect of Chronic Administration of Low Dose Rapamycin on Development and Immunity in Young Rats.

PloS one (2015-08-08)
Zhenya Lu, Furong Liu, Linglin Chen, Huadan Zhang, Yuemin Ding, Jianxiang Liu, Michael Wong, Ling-Hui Zeng
RESUMEN

Mammalian target of rapamycin (mTOR) regulates cell growth, cell differentiation and protein synthesis. Rapamycin, an inhibitor of mTOR, has been widely used as an immunosuppressant and anti-cancer drug. Recently, mTOR inhibitors have also been reported to be a potential anti-epileptic drug, which may be effective when used in young patients with genetic epilepsy. Thus, a suitable dose of rapamycin which can maintain the normal function of mTOR and has fewer side effects ideally should be identified. In the present study, we first detected changes in marker proteins of mTOR signaling pathway during development. Then we determined the dose of rapamycin by treating rats of 2 weeks of age with different doses of rapamycin for 3 days and detected its effect on mTOR pathway. Young rats were then treated with a suitable dose of rapamycin for 4 weeks and the effect of rapamycin on mTOR, development and immunity were investigated. We found that the expression of the marker proteins of mTOR pathway was changed during development in brain hippocampus and neocortex. After 3 days of treanent, 0.03 mg/kg rapamycin had no effect on phospho-S6, whereas 0.1, 0.3, 1.0 and 3.0 mg/kg rapamycin inhibited phospho-S6 in a dose-dependent manner. However, only 1.0 mg/kg and 3.0 mg/kg rapamycin inhibited phospho-S6 after 4 weeks treatment of rapamycin. Parallel to this result, rats treated with 0.1 and 0.3 mg/kg rapamycin had no obvious adverse effects, whereas rats treated with 1.0 and 3.0 mg/kg rapamycin showed significant decreases in body, spleen and thymus weight. Additionally, rats treated with 1.0 and 3.0 mg/kg rapamycin exhibited cognitive impairment and anxiety as evident by maze and open field experiments. Furthermore, the content of IL-1β, IL-2, IFN-γ, TNF-α in serum and cerebral cortex were significantly decreased in 1.0 and 3.0 mg/kg rapamycin-treated rats. The expression of DCX was also significantly decreased in 1.0 and 3.0 mg/kg rapamycin-treated rats. However, rats treated with 1.0 mg/kg rapamycin exhibited fewer and milder side effects than those treated with 3.0 mg/kg. In summary, all these data suggest that there is not a rapamycin dose that can inhibit mTOR for epilepsy without causing any side effects, but 1 mg/kg may be the optimal dose for young rats for suppressing mTOR with relatively few side effects.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Sacarosa, for molecular biology, ≥99.5% (GC)
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Sacarosa, ≥99.5% (GC)
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
DAPI, for nucleic acid staining
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Sacarosa, ≥99.5% (GC), BioXtra
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Sacarosa, BioUltra, for molecular biology, ≥99.5% (HPLC)
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Sacarosa, ≥99.5% (GC), BioReagent, suitable for cell culture, suitable for insect cell culture
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Sacarosa, ≥99.5% (GC)
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Sacarosa, ≥99.5% (GC), Grade II, suitable for plant cell culture
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Alcohol etílico puro, 190 proof, ACS spectrophotometric grade, 95.0%
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Sacarosa, Grade I, ≥99% (GC), suitable for plant cell culture
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Alcohol etílico puro, 200 proof, anhydrous, ≥99.5%
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Sacarosa, meets USP testing specifications
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Supelco
Ethanol solution, 10 % (v/v) in H2O, analytical standard
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Sacarosa, ACS reagent
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Alcohol etílico puro, 190 proof, meets USP testing specifications
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Sacarosa, puriss., meets analytical specification of Ph. Eur., BP, NF
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
Bicinchoninic acid disodium salt hydrate, ≥98% (HPLC)
En este momento no podemos mostrarle ni los precios ni la disponibilidad